Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator.

ABSTRACT: A novel series of alkoxyimino derivatives as S1P1 agonists were discovered through de novo design using FTY720 as the chemical starting point. Extensive structure-activity relationship studies led to the discovery of (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid (32, BAF312, Siponimod), which has recently completed phase 2 clinical trials in patients with relapsing-remitting multiple sclerosis.

SUBMITTER: Pan S 

PROVIDER: S-EPMC4027137 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature